The management of metastatic GIST: current standard and investigational therapeutics

CM Kelly, L Gutierrez Sainz, P Chi - Journal of Hematology & Oncology, 2021 - Springer
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the
gastrointestinal tract. The majority of GISTs harbor gain of function mutations in either KIT or …

[HTML][HTML] Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: A systematic review and meta-analysis

M Saerens, N Brusselaers, S Rottey… - European Journal of …, 2021 - Elsevier
Abstract Background Soft-tissue sarcomas (STSs) are rare malignancies, accounting for
approximately 1% of adult cancer. Metastatic disease carries a poor prognosis, and various …

Improving immunotherapy efficacy in soft-tissue sarcomas: A biomarker driven and histotype tailored review

M Roulleaux Dugage, EF Nassif, A Italiano… - Frontiers in …, 2021 - frontiersin.org
Anti-PD-(L) 1 therapies yield a disappointing response rate of 15% across soft-tissue
sarcomas, even if some subtypes benefit more than others. The proportions of TAMs and …

Homologous recombination proficiency in ovarian and breast cancer patients

JF Creeden, NS Nanavaty, KR Einloth, CE Gillman… - BMC cancer, 2021 - Springer
Homologous recombination and DNA repair are important for genome maintenance.
Genetic variations in essential homologous recombination genes, including BRCA1 and …

Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers

B Li, H Chen, S Yang, F Chen, L Xu, Y Li, M Li, C Zhu… - Molecular cancer, 2023 - Springer
Mesenchymal gastrointestinal cancers are represented by the gastrointestinal stromal
tumors (GISTs) which occur throughout the whole gastrointestinal tract, and affect human …

[HTML][HTML] Immunotherapy for sarcomas: new frontiers and unveiled opportunities

HK Birdi, A Jirovec, S Cortés-Kaplan… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Sarcomas are a rare malignancy of mesenchymal tissues, comprizing a plethora of unique
subtypes, with more than 60 types. The sheer heterogeneity of disease phenotype makes …

Biology and management of dedifferentiated liposarcoma: state of the art and perspectives

J Nishio, S Nakayama, K Nabeshima… - Journal of Clinical …, 2021 - mdpi.com
Dedifferentiated liposarcoma (DDL) is defined as the transition from well-differentiated
liposarcoma (WDL)/atypical lipomatous tumor (ALT) to non-lipogenic sarcoma, which arises …

Beyond the driver mutation: immunotherapies in gastrointestinal stromal tumors

M Roulleaux Dugage, RL Jones, J Trent… - Frontiers in …, 2021 - frontiersin.org
Gastrointestinal stromal tumors (GISTs) are a subtype of soft tissue sarcoma (STS), and have
become a concept of oncogenic addiction and targeted therapies. The large majority of …

[HTML][HTML] Recent advances in the understanding and management of liposarcoma

CL Haddox, RF Riedel - Faculty reviews, 2021 - ncbi.nlm.nih.gov
Liposarcomas are a common subfamily of soft tissue sarcoma with several subtypes
recognized by the World Health Organization: atypical lipomatous tumors (ALT)/well …

Desmoplastic small round cell tumor: a review of main molecular abnormalities and emerging therapy

CA Mello, FAB Campos, TG Santos, MLG Silva… - Cancers, 2021 - mdpi.com
Simple Summary Desmoplastic small round cell tumor is a rare neoplasm with extremely
aggressive behavior. Despite the multimodal treatment for newly diagnosed patients with …